Berisha and Meta in unison against PS-PD co-government, messages and warnings to Basha to reject Rama's offer
The cocktail that healed Trump! European Agency issues IMPORTANT notification, authorizes drug treating coronavirus
Written by SOT.COM.AL 26 Shkurt 2021
According to the EMA Committee on Medicinal Products for Human Use, the "combination" of monoclonal antibodies "also known as REGN-COV2" can be used to treat Covid-19 "in patients" who do not require additional oxygen and who are with high risk ".
This was announced by the European Medicines Agency, EMA. The monoclonal antibody cocktail 'Casirivimab' and 'Imdevimab' for the treatment of Covid-19 positive patients was created by the American company Regeneron Pharmaceuticals and was already used to treat the then President of the United States, Donald Trump, before the US Food Administration and Drugs (FDA) approve it.
The EMA started reviewing REGN-COV2 last February 1. "The review - the Agency recalls - was undertaken to ensure a harmonized scientific opinion at EU level to support the national decision-making process on the possible use of antibodies prior to marketing authorization."